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PREDICTIVE TESTING IN THE WORKPLACE-COULD THE
GERMAN MODEL SERVE AS A BLUEPRINT FOR UNIFORM
LEGISLATION IN THE UNITED STATES?
Eva Lorenz'
This Comment focuses on the problems associated with the use
of employment-based genetic testing. Recently, the German
National Ethics Council ("NEC") drafted a list of
recommendations to regulate the use of predictive testing in the
workplace. This problem of genetic testing is not limited to
Germany-similar cases have been reported in the United States.
The lack of a federal framework to regulate the use of genetic
testing in the workplace creates uncertainty for employees and
employers. Though it is likely that any federal framework will
require amendments, the increased certainty associated with a
uniform federal law will likely outweigh any shortcomings. This
Comment analyzes the recommendations of the NEC as a possible
blueprint for a uniform law in the United States.
"[O]nce a tool is developed there are
considerable pressures for implementation."'
I. INTRODUCTION
Imagine you are a thirty-six year old woman who always
wanted to become a teacher. You have finished high school,
graduated from college, passed all of the professional tests, and are
now on the verge of getting a tenure track position to teach. Just
one more test and you will be there. There is a problem, however,
J.D. Candidate, University of North Carolina School of Law, 2007. Dr.
Lorenz was awarded a Ph.D in Genetics from the University of Iowa in 1995.
Her research expertise is in the genetics of innate immunity.
2 David L. Wiesenthal & Neil I. Wiener, Privacy and the Human Genome
Project, 6 ETHICS & BEHAV. 189, 196 (1996).
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and it is that the final test is a physical examination, which is a
requirement for public servants seeking tenure track positions.
Part of the physical is a questionnaire that seeks information about
family health history. You put down that your father has
Huntington's disease ("HD", also called Huntington's chorea).'
You pass your physical, but are still denied a teaching position by
the state. Why? Because you have a high risk of carrying the
Huntington's gene and therefore have a high likelihood of
developing an incurable disease that may force you to seek early
retirement.
While this sounds like a fictional story from George Orwell4 or
Aldous Huxley,5 this was the reality faced by a young woman in
Germany, and it could happen in any country where medicine has
advanced enough to enable testing for inherited diseases. The fact
that the young woman had a fifty percent chance of carrying a
disease gene was deemed sufficient by a lower court in Germany
to deny her a teaching position. The woman appealed, arguing that
she has a fifty percent chance of being healthy and that questions
regarding the health status of close relatives should not be part of a
physical that seeks to determine whether she is fit to teach.6 The
administrative court granted her relief and she was given a
teaching position.
Despite the positive outcome for the plaintiff, some concerns
remain. The language of the decision and the recommendations of
3 Homepage of the Huntington's Disease Society of America,
http://www.hdsa.org/ (last visited Mar. 3, 2006) (on file with the North Carolina
Journal of Law & Technology).
4 GEORGE ORWELL, NINETEEN EIGHTY-FOUR (Dramatic Publishing 1963)
(1949).
5 ALDous HUXLEY, BRAVE NEW WORLD (Harper Perennial Modem Classics
1998) (1932).
6 Huntington's Disease Frequently Asked Questions, at http://www.hdsa.org/
(follow "Get Help/Info/Leam" hyperlink; then follow "FAQs" hyperlink) (last
visited Mar. 3, 2006) (on file with the North Carolina Journal of Law &
Technology). "HD affects males and females equally and crosses all ethnic and
racial boundaries. Each child of a person with HD has a 50/50 chance of
inheriting the fatal gene. Everyone who carries the gene will develop the
disease." Id.
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the German National Ethics Council7 ("NEC") leave open what
kind and how much information should be shared with third parties
as part of pre-employment physicals.
This Comment presents a critical analysis of the NEC
recommendations for the use of predictive testing in the workplace
and their possible use as a blueprint for comparable legislation in
the United States. A federal law would generate certainty
regarding the use of predictive testing in the workplace by
replacing the existing patchwork of laws and regulations. While
many people already view genetic testing with suspicion, it is
important to keep in mind that predictive testing can be useful in
determining whether certain people are at an increased risk for
exposure-related illnesses. A balance between the benefits of
predictive testing in protecting workers from exposure hazards and
the possible abuses of testing for discriminatory purposes is best
achieved through a uniform law at the federal level that covers all
employees and employers. Part II of this Comment is a primer on
genetics and genetic testing. Part III provides a brief introduction
to the NEC and analyzes the recommendations of the NEC dealing
with the use of predictive testing in the workplace. The NEC
recommendations are compared to existing legislation in the
United States to determine whether the NEC proposal should serve
as a template for uniform federal laws in the United States While
the United States does not have a national law regarding the use of
genetic testing to determine employment eligibility, the Americans
7 See NEC, Predictive health information in pre-employment medical
examinations, Aug. 16, 2005, available at http://www.ethikrat.org (follow
"English version" hyperlink; then follow "Publications" hyperlink and select
"Predictive health information in pre-employment medical examinations"
hyperlink) (last visited Mar. 3, 2006) (on file with the North Carolina Journal of
Law & Technology).
8 Heidrun Graupner, Angst, Hysterie und das Schubladen-Prinzip: Die
Diskussion um die Gendiagnostik am Beispiel einer Lehrerin (Sie sollte nicht
Beamtin werden diirfen, weil ihr Vater an Chorea Huntington litt-ihr Fall
macht deutlich, dass es dringend eines Gesetzes bedar), Suedeutsche Zeitung,
Mar. 11, 2005, at 3 (stating that, in Germany, roughly 90,000 genetic tests are
performed and that private laboratories offering genetic testing have a growth
rate of forty to fifty percent).
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with Disabilities Act,9 state-based laws, and pending federal
legislation indicate that there have been attempts to regulate
genetic testing in this country. Part IV summarizes the existing
case law, which demonstrates the need for a better legal
framework, and will also reiterate the danger of using genetic
testing as a discriminatory tool in the workplace. Part V analyzes
the split in the minority community regarding access to genetic
testing, which underscores the need for an in-depth debate on the
future use of employment-based predictive testing in the United
States.
Currently, genetic information about employees in this country
is protected to some degree through a mixture of case law, state-
based legislation, and federal statutes. However, a uniform federal
framework is necessary to minimize the abuses and uncertainties
that are possible under the current system, and the proposal by the
NEC may provide some guidance for the establishment of such a
federal framework. While attempts at establishing such a
framework may evoke opposition from groups that fear possible
discriminatory uses, the increased certainty associated with
uniform federal rules as well as the possibility of covering all
employees lend support to establishing such a framework at the
federal level to replace the existing patchwork of laws and statutes.
This Comment, therefore, uses the comparison with the NEC
recommendations to point out how a federal law regulating genetic
testing in the workplace could be structured for use in the United
States in order to increase the certainty associated with the use of
predictive testing in the workplace.
II. PRIMER ON GENES AND GENETIC TESTING
Before analyzing the recommendations by the National Ethics
Council of Germany,1" a short introduction to genetic testing is
helpful. The following paragraphs explain and highlight the basics
9 Americans with Disabilities Act of 1990, 42 U.S.C. §§ 12101-12213 (2000)
[hereinafter "ADA"].
'o See NEC, supra note 7.
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of genetic testing, its current applications, and some of its
weaknesses. "
DNA, short for deoxyribonucleic acid, is the carrier of genetic
information, and its content determines such things as the physical
appearance of the person, as well as what diseases a person may
have inherited from his or her parents. The physical appearance
and the effects of any inherited diseases, referred to as the
phenotype, are differentiated from the genetic make up of a person
called genotype. 2 DNA is transcribed into messenger ribonucleic
acid ("mRNA"). 3 RNA is closely related to DNA in its chemical
composition. mRNA is translated into proteins, such as enzymes,
that regulate all biological processes in mammals and are therefore
crucial for biological functions, such as metabolism, growth, and
healing. Since changes in the DNA, called mutations, 4 translate
into changes in the proteins that may affect the function of
enzymes, much of modem day medicine is intent on discovering
the underlying mutations that cause diseases ranging from asthma
to cystic fibrosis ("CF").
Some diseases, such as cystic fibrosis 5 or Huntington's chorea,
can be linked to mutations in a single gene. Other diseases, called
complex diseases, which include asthma or heart disease, are
believed to be caused by a number of genetic changes as well as
environmental influences. Determining the genetic causes for
11 Roberta A. Pagon, M.D., Editorial: Genetic Testing: When to Test, When
to Refer, 72 AM. FAM. PHYSICIAN 1 (2005).
12 Many studies are so-called genotype-phenotype correlation studies, in
which changes in the genetic makeup of a person (genotype) are correlated with
effects on the phenotype, such as the development of certain diseases or specific
features of a person. Obesity is not only a topic of lawsuits against fast food
restaurants, but also an area of intense genetic research, in which a number of
genes during the past years have been implicated as possible causes.
13 The specific chemical structure of RNA, DNA, and the various other
carriers of genetic information are not important to the understanding of genetic
aspects covered in this paper. The interested reader can find an introduction to
basic genetic principles in any introductory genetics textbook. One commonly
used textbook is by ANTHONY J. F. GRIFFITHS ET AL., INTRODUCTION TO
GENETIC ANALYSIS (W.H. Freeman, 8th ed. 2004).
14 WEBSTER'S NEW COLLEGIATE DICTIONARY 783 (9th ed. 1990).
15 See Rowntree, infra note 17.
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complex diseases is still in the initial stages and disease prevention
is currently limited to identifying risk factors for the development
of such diseases. Merely knowing that mutations in only one gene
underlie a specific disease does not mean that physicians or genetic
counselors can answer all the questions a person may have
regarding disease severity, age of onset or life expectancy. This
lack of conclusive information regarding the resulting phenotype is
based on differences in penetrance. 6 In some genes, such as the
cystic fibrosis Transmembrane Reporter ("CFTR"), a large number
of mutations throughout the gene have been identified that cause
phenotypes ranging from a very mild form of CF that may go
unnoticed until adulthood, to severe forms, in which the disease
manifests itself in early childhood." In Huntington's chorea,
penetrance of the disease phenotype is based on a number of
trinucleotide repeats. 8 Such repeats are present throughout the
human genome and can range from three bases to five or more
bases being repeated. The mutations in Huntington's chorea are
limited to a stretch of nucleotide repeats that even in healthy adults
differ in lengths. The fact that even healthy individuals display a
variability in the number of repeats makes the job of the genetic
counselor all the more difficult, since the initial diagnosis with
Huntington's is often followed by questions from the tested
16 Penetrance is a measure of how strongly a mutation will be evident in the
phenotype. Complete penetrance means that in almost all carriers of the
mutation, the presence of the mutation will result in some change in the
phenotype. An example of complete penetrance is the mutation for Tay-Sachs
disease. Carriers of this disease develop symptoms of the disease shortly after
birth and have a very limited life span. Mutations that show a weak penetrance,
by contrast, may go unnoticed in many individuals. See Daniel Eisenberg, The
Ethics of Genetic Screening, Jan. 9, 2005, available at http://www.aish.com
(follow hyperlink "society today"; then follow hyperlink "society"; and click on
"The Ethics of Genetic Screening") (last visited Mar. 3, 2006) (on file with the
North Carolina Journal of Law & Technology).
17 Rebecca K. Rowntree & Ann Harris, Review: The Phenotypic
Consequences of CFTR Mutations, 67 ANN. HUM. GENET. 471 (2003).
18 Trinucleotide is defined as a "a nucleotide consisting of three
mononucleotides in combination." WEBSTER'S NEW COLLEGIATE DICTIONARY
1262 (9th ed. 1990). In Huntington's chorea the specific repeat is "CAG."
[VOL. 7:487
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individual related to age of onset and disease severity. 9 For
Huntington's, less than thirty repeats do not precipitate the
development of the disease, while affected individuals have more
than thirty-six repeats.2°
The autosomal dominant nature of the disease explains why
every person who has more than thirty-six CAG repeats develops
Huntington's chorea.21  In the inheritance of disease traits,
autosomal dominant means that one copy of the mutation or
disease-causing gene is sufficient to exhibit disease traits. In
19 See Huntington's Disease Society of America, Frequently Asked Questions
about HDSA and HD, supra note 6.
HD typically begins in mid-life, between the ages of 30 and 45, though
onset may occur as early as the age of 2. Children who develop the
juvenile form of the disease rarely live to adulthood. HD affects males
and females equally and crosses all ethnic and racial boundaries. Each
child of a person with HD has a 50/50 chance of inheriting the fatal
gene. Everyone who carries the gene will develop the disease. In
1993, the HD gene was isolated and a direct genetic test developed
which can accurately determine whether a person carries the HD gene.
The test cannot predict when symptoms will begin. However, in the
absence of a cure, some individuals 'at risk' elect not to take the test.
Id.
20 Zenjiro Matsuyama et al., Molecular Features of the CAG Repeats of
Spinocerebellar Ataxia 6 (SCA6), 6 HuM. MOL. GEN. 8, 1283 (1997).
21 Id. Autosomal dominant describes a mode of inheritance, in which one
copy of a disease gene is sufficient for the development of the disease.
"Autosomal" refers to the classification of chromosomes into autosomes that are
present in all humans and sex chromosomes that differ between males and
females. Humans have twenty-three pairs of chromosomes and therefore two
copies of each gene expressed on a specific chromosome. "Dominant" describes
the requirement for one of two copies of a gene to be required for the expression
of the disease phenotype. See Winkelman, infra note 22.
22 Chris Winkelman, Genomics: What Every Critical Care Nurse Needs to
Know about the Genetic Contribution to Critical Illness, CRITICAL CARE NURSE,
Vol. 24, No. 3, Jun. 2004, at 36. The autosomal dominant is defined as:
Autosomal dominant: In this pattern, an abnormality or abnormalities
appear with only a single copy of the disease allele; usually the
abnormality appears in every generation. Each child of an affected
parent has a 50% chance of inheriting the disease. Males and females
are equally likely to have and transmit the disease. The 50% chance of
inheriting the disease is based upon the calculation that each parent has
two copies of the respective gene (in this case Huntington's) and that
N.C.J.L. & TECH.
terms of inheritance, autosomal dominant diseases are inherited
with fifty percent likelihood by the children (sons and daughters)
of an affected parent.23 Therefore, the autosomal dominant nature
of Huntington's chorea means that the teacher described in the
Introduction has a fifty percent chance of inheriting the disease.24
Testing for disease-associated mutations has become more
efficient and affordable as genotyping techniques advance.25
Usually, genetic testing involves using small amounts of blood to
extract the DNA for polymerase chain reaction ("PCR")-based
genotyping 6 PCR denotes a process by which short stretches of
the one parent suffering from Huntington's will have a mutated copy of
the gene. Of the four copies of the Huntington's gene present in the
parents, one out of four will therefore be able to carry the disease into
the offspring generation. Since each child will only inherit one copy of
the gene from each parent (to generate the pairs of chromosomes
present in each human being), two out of the four copies of the gene
will be inherited by the children. The parent suffering from
Huntington's has a 50% chance that the copy of the gene he or she
passes on to the child will carry the mutation, giving the child a 50%
chance of developing the disease. This calculation is based on the
assumption that the parent suffering from Huntington's has only one
copy of the mutated gene, which is the case in the vast majority of
cases. If the parent were to express two copies of a mutated gene,
inheritance of a disease would be 100%, since any copy of the gene
passed on by the parent to the child would express the mutation.
Autosomal modes of inheritance mean that sons and daughters have
equal chances of inheriting the mutated gene, since autosomes are
inherited by children of any sex. Dominant mode of inheritance means
that one copy of the mutated gene, inherited from either mother of
father, is sufficient to cause expression of the disease.
Id.
23 Id.
2 4 
Id.
25 Currently, genetic testing is available for 954 clinical diseases. See
National Institutes of Health, GeneTests, available at http://www.genetests.org
(last visited Apr. 3, 2006) (on file with the North Carolina Journal of Law &
Technology).26Ayalew Tefferi et al., Primer on Medical Genomics Part II: Background
Principles and Methods in Molecular Genetics, 77 MAYO CLIN. PROC. 8, 785-
808 (2002) (providing an introduction to molecular genetics, including
commonly used terms).
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DNA known to carry the disease gene are amplified and a certain
banding pattern is used to determine the presence of the mutation.27
In many cases, simply finding a specific mutation associated
with a disease does not indicate that the carrier (the person
expressing the mutation) will actually develop the disease.28 The
differences in penetrance of genes determine whether a mutation
will actually cause the carrier to develop signs of the disease.29 In
addition, mutations can have varying effects depending on the
remaining genetic makeup of the person; some genes are
modulated in expression by other genes so that the effect of a
mutation is dependent on genes throughout the DNA.3"
In the example of Huntington's chorea, more than thirty-six
repeats will identify a person as a carrier who will eventually
develop the disease because of its autosomal dominant nature.3 A
troubling aspect in counseling Huntington's chorea patients is
related to the uncertainty of when the disease will manifest itself
and the life expectancy of the patient.32 In the case of the teacher
in Germany, a genetic test would determine whether she is a carrier
for the disease or not. The optimum outcome of such a test would
indicate the presence of thirty or fewer CAG repeats in the
Huntington's gene, indicating that she will not develop the disease.
A more troubling outcome would be the detection of more than
2 7 id.
28 Winkelman, supra note 22, at 37 ("Penetrance refers to the probability that
disease will appear when a disease-related genotype is present.").29 Id. The meaning of "penetrance" is defined as:
[a] trait with incomplete penetrance is characterized by a specific
genotype but a varied phenotype; that is, persons with the same genetic
anomaly (abnormal genotype) do not have the same abnormal signs,
symptoms, and complex disease. An example of a trait with
incomplete penetrance is the polydactyl trait. The same genotype
might "penetrate" as an extra finger, a small tag, or not at all.
Id.
30 Garry R. Cutting, Review: Modifier Genetics: Cystic Fibrosis, 6 ANN.
REv. GENOMICS & HUM. GENET. 237 (2005).
31 Richard H. Myers, Huntington's Disease Genetics, 1 NEURORX 255 (2004).
32 Id. at 257 ("The 34-year span in onset demonstrates not only the poor
predictive power for onset of the repeat size, but also the substantial variation in
onset age that is not explained by the HD repeat.").
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thirty-six CAG repeats. The age of onset may be the most
troubling aspect of genetic counseling for Huntington's disease
carriers. While it is possible for the first sign of Huntington's to be
visible in a carrier's early forties33 and to affect the carrier's ability
to work as a teacher before she reaches the retirement age, it is
equally possible that the young teacher will have no symptoms
until after she reaches the retirement age.34 In the latter case, a
diagnosis as a carrier of Huntington's chorea, while perhaps
putting a heavy psychological burden on the individual, would in
no way affect her physical ability to work as a teacher. This
situation exemplifies the problems associated with some genetic
testing. While disease carriers can be identified in a
straightforward way, the uncertainty about the effect the disease
will have on their lives remain unanswered. This uncertainty,
especially in the case of debilitating diseases such as Huntington's,
often exacts a toll on the individual that is as significant as the
eventual physical effects. Add into this equation the potential of
losing one's job or health insurance and it becomes understandable
that some people who know they are at risk for specific genetic
diseases refuse to get tested and prefer to live with the uncertainty
of their carrier status.
The ability of genetic testing to determine who is at risk for
inherited diseases is an area not properly addressed by existing
laws. This will become obvious in the later sections of this
Comment dealing with employees in the United States who seek
protection against workplace discrimination through the ADA.
Employees at risk for inherited diseases such as Alzheimer's,
Multiple Sclerosis, or Huntington's may find it more difficult to
fight discriminatory employment practices than employees with
obvious disabilities, even though they are currently asymptomatic.
So far, no studies have addressed how positive genetic test results
fit into the spectrum of disabilities.35 All developed countries have
33 Id.
34 Id.
35 Meera Adya & Brian H. Bornstein, Genetic Information and Discrimination
in Employment: A Psycho-Legal Perspective, 32 WM. MITCHELL. L. REv. 265,
285 (2005) (providing an in depth discussion on how the various disabilities are
viewed in an employment context). Adya and Bornstein cite various studies that
[VOL. 7:487
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taken part in the genetics revolution that makes genetic testing for
inherited diseases possible. The proposals and frameworks
developed in other countries for regulating such genetic testing
may serve as a template for uniform federal regulation in the
United States. This Comment discusses one such proposal by the
NEC.
III. ANALYSIS OF THE NEC RECOMMENDATIONS AND CURRENT
UNITED STATES LAW
A. History and Function of the German National Ethics Council
As a response to the technological advances in the life sciences
and the need to get up-to-date policy recommendations, the NEC
was founded by a mandate of the German Government on June 8,
2001.36 The purpose of the NEC is to generate a forum for dealing
with ethical questions related to life sciences.37 The NEC has
twenty-five permanent members with backgrounds in the natural
sciences, medicine, theology, philosophy, economics, ecology,
law, and social sciences.38 The members, who are nominated by
the Chancellor, constitute an independent forum that is only bound
to adhere to the duties enumerated in the initial mandate.39 The
NEC is expected to work with the public and similar organizations
indicate that the physically disabled are discriminated against less than people
with mental or neurological problem. The authors also cite a possibly overly
"deterministic interpretation of positive genetic tests," whereby a positive test is
equated to the person having an actual disability. Id.
36 See NEC, Function, available at http://www.ethikrat.org (follow hyperlink
"English version"; then follow hyperlink "about us") (describing the mission of
the NEC) (last visited Mar. 6, 2006) (on file with the North Carolina Journal of
Law & Technology). It is important to note that the NEC does not have
lawmaking authority, but has a purely advisory role.
3 7 
id.
38 id.
39 See NEC, Decree, available at http://www.ethikrat.org (follow hyperlink
"Decree") (last visited Mar. 6, 2006) (on file with the North Carolina Journal of
Law & Technology).
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throughout Germany and the rest of the world.4" In response to the
case of the young teacher at risk of developing Huntington's, the
NEC compiled a series of recommendations to regulate predictive
testing in the workplace. The NEC's recommendations will be
addressed in more detail in the subsequent sections of this
comment.
B. Summary of Issues Raised by the Court's Decision
In 2004, the administrative court in Darmstadt determined that
the denial of a tenure-track position to a teaching candidate at risk
for developing Huntington's chorea was not legal." This decision
propelled the issue of genetic testing in the workplace into the
headlines and, in part, contributed to the development of the NEC
recommendations. Though the court found in favor of the plaintiff,
the decision also indicates that genetic testing and inquiries into
genetic risks are acceptable in certain situations.42 For example,
the court stated that it was permissible to inquire about the
presence of inheritable diseases among the applicant's family
members without the family members' consent.43 The court
justified such inquiries with the government's right to hire only
people who are sufficiently physically fit to work until they reach
40 See NEC, supra note 36 (stating that the NEC is seeking to collaborate with
other ethics societies in Germany and groups with similar interests in other
countries).
41 See NEC, Pradiktive Gesundheitsinformationen bei
Einstellungsuntersuchungen, Aug. 2005, available at http://www.ethikrat.org
(follow hyperlink "Stellungnahmen" and then select "Pradiktive
Gesundheitsinformationen bei Einstellungsuntersuchungen") (citing
Verwaltungsgericht [VG] [Administrative Court] June 24, 2004 Az: 1E
470/04(3) (F.R.G.)) (last visited Mar. 3, 2006) (on file with the North Carolina
Journal of Law & Technology).
42 Oliver Tolmein, Uberwiegend unwahrscheinlich Recht auf Nichtwissen:
Das Urteil des Verwaltungsgerichts im Gentest-Prozefi einer Lehrerin,
FRANKFURTER ALLGEME1NE ZEITUNG, June 28, 2004, at 30 (on file with the
North Carolina Journal of Law & Technology).
43 Oliver Tolmein, Gesundheit auf Probe, Gen-ethischer Informationsdienst,
Aug./Sept. 2004, at 36, available at http://www.gen-ethisches-
netzwerk.de/gid/TEXTE/GID-ARCHIV-INDEX.HTML (follow "GID 165"
hyperlink; then follow "Gesundheit auf Probe" hyperlink) (last visited Mar. 3,
2006) (on file with the North Carolina Journal of Law & Technology).
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the legal retirement age44 and held that inquiries into the health of
family members were necessary to serve this purpose.45 The court
concluded that in these situations, state-based privacy laws allow
such questioning without consent of the affected individuals. 46 At
the same time, the court rejected a government's right to demand
genetic testing under existing law and opined that this would
constitute an impermissible invasion of privacy.47 The court
reasoned that appropriate laws would have to be passed in order to
demand such testing.4" Since the court based its decision on
several areas of law, such as privacy rights and the special
responsibilities of public servants, it is worthwhile to analyze the
specific NEC recommendations in detail.
C. Summary of the NEC Recommendations"'
The NEC recommendations begin with the basic premise that
the predictive power of genetic testing is comparable to the
predictive power of more traditional disease-causing risk factors,
such as blood chemistry and radiology." Since traditional
approaches, such as using blood pressure measurements to
determine a person's risk for developing heart disease, can also be
used to assess the development of a future disease, genetic testing
is seen as a modem extension of these traditional means.5 The
44id.
45 Id. The judges specifically stated that in determining the health of a job
applicant, information regarding inherited diseases of family members is
required. Id.46 Id.
47 Id.
48 id.
49 See NEC, Predictive Health Information in Pre-employment Medical
Examinations, Aug. 16, 2005, available at http://www.ethikrat.org (follow
"English version" hyperlink; then follow "Publications" hyperlink and select
"Predictive health information in pre-employment medical examinations"
hyperlink) (last visited Mar. 3, 2006) (on file with the North Carolina Journal of
Law & Technology).50 Id.
51 Medical Experts Redefine Hypertension, BIOTECH WEEK, June 8, 2005, at
77 ("Leading U.S. hypertension experts have expanded the definition of
hypertension beyond the numbers obtained from a blood pressure reading, and
instead, urge that blood pressure be viewed as a part of a patient's overall risk
SPRING 2006] 499
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recommendations by the NEC therefore apply to all kinds of
predictive testing, including non-genetic tests." The NEC, in
general, permits questions regarding the physical health of the
applicant so long as the information contributes to assessing the
health of the applicant at the time the job begins. 3 However,
inquiries regarding possible future problems are only permitted if
they relate to the disease or disability-risk within a contractually
set time-frame after the job starts during which the employment
contract may be canceled by either party, such as a six-month
training period. 4 Inquiries about family history of diseases are
explicitly forbidden and all tests require the consent of the
applicant." The physician performing the physical may only share
the general assessment of the job applicant fitness for the job with
a prospective employer; no specifics regarding the results of any
tests are to be shared with third persons.56 However, in professions
for cardiovascular disease.") (on file with the North Carolina Journal of Law &
Technology).
52 See NEC, Prddiktive Gesundheitsinformationen bei
Einstellungsuntersuchungen, Aug. 2005, available at http://www.ethikrat.org/
(follow hyperlink "Stellungnahmen" and select "Prdidiktive
Gesundheitsinformationen bei Einstellungsuntersuchungen") (last visited Mar.
3, 2006) (on file with the North Carolina Journal of Law & Technology).
53 See NEC, infra note 55, at 53 ("Unlike a private-sector employer, who can
dismiss an employee on the grounds of ill health, his public-sector counterpart
lacks the possibility of terminating a permanent civil servant's contract if he
becomes permanently unfit for work owing to illness. In this situation, the
public-sector employer has an understandable interest, when a candidate
undergoes an official medical examination for the purposes of appointment as a
permanent civil servant, not only in establishment of the candidate's current
health-related fitness, but also in predictions of his likely future fitness.").
54 See NEC, infra note 55, at 56 ("This suggests that it should be permissible
for predictive and prognostic health information to be demanded and used only
in the case of conditions and predispositions with more than a 50% probability
of having a non-negligible effect on an applicant's health-related fitness within
the next five years.").
55 See NEC, Predictive health information in pre-employment medical
examinations, Aug. 16, 2005, available at http://www.ethikrat.org, at 58-59
(Recommendations #3 and #7) (follow "English version" hyperlink; then follow
"Publications" hyperlink and select "Predictive health information in pre-
employment medical examinations" hyperlink) (last visited Mar. 3, 2006) (on
file with the North Carolina Journal of Law & Technology).56Id. at 59 (Recommendation #8).
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involving possible risks to third persons, such as pilots, applicants
may be subject to further tests in order to minimize the risk to the
public." Also allowed are specific tests used to assess the risk that
an individual will develop diseases due to workplace exposure." If
such tests are not required by law, the applicant must be informed
of the availability of such tests for his own physical protection."
The NEC loosens some of these recommendations with respect
to civil servants, most of whom will reach a tenured employment
status and whose contracts cannot be dissolved in case of disability
or serious illness.6" The NEC states that the government and the
general public have a significant interest in hiring only physically
fit persons as public servants so as to ensure long-term
employment.6' The NEC further states that due to the low
incidence of job applicants for whom genetic testing can be used to
predict disability, enabling such persons to achieve tenured status
will not significantly increase the numbers of public servants
seeking early retirement.62 Therefore, the NEC recommends a
five-year limit in which a disease would have to manifest itself to
57 Id. at 58 (Recommendation #5) ("More thoroughgoing examinations for
currently symptom-free or predictable conditions are permissible if they are
necessary having regard to the principle of proportionality in order to preclude
specific third-party risks inherent in the nature of the activity (e.g. in the case of
pilots, bus drivers or kitchen staff).").
58 Id. at 59 (Recommendation #9).
59 Id. at 59 (Recommendation #10).
60 See NEC, supra note 7, at 60. The limits on disclosure of information are:
By analogy with the regulations applicable in the individual Federal
Lander to the appointment of severely disabled persons as permanent
civil servants, it should be permissible to demand and use predictive
and prognostic information only if it relates to disorders or
predispositions that will have non-negligible effects on an applicant's
health-related fitness in the next five years.
Id.
61 Id. at 59 (Recommendation #11) ("The principles set out above cannot be
applied without reservation to the appointment of permanent civil servants. In
this instance, the public-sector employer assumes a duty of care towards and
hence an obligation to provide for the welfare of, a civil servant that persist
throughout his life (even in the event of premature incapacity for work).").
62 Id. at 60 (Recommendation #12).
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justify excluding an applicant from obtaining tenured positions.63
Essentially, the NEC recommends that predictive information
about future diseases can only be ascertained and used in judging
the applicant's fitness for the job in the public sector if there is
more than fifty percent risk of developing a disease that will
significantly affect the fitness of the applicant to perform his
assigned duties within the first five years of the employment
contract. 64
D. Current Legislation in the United States Regarding Genetic
Discrimination in the Workplace
There is an obvious need for uniform, national legislation that
regulates the use of predictive testing in the workplace. As stated
previously, there currently is no such uniform law regulating the
use of predictive testing for non-federal employees in the
workplace.65 While concern about the discriminatory use of
predictive testing has been widespread, an Executive Order by
President Clinton in February 2000 was the first attempt to create a
federal policy that prohibits federal agencies from obtaining
genetic information about their employees or job applicants, or
from using genetic information in hiring and promotion
decisions.66 In justifying the Executive Order, President Clinton
cited "equal treatment under the law" as an important basis for his
decision.67 While mostly cited in the context of health insurance
63 Id. (Recommendation # 13).
64 Id. (Recommendation # 14).
65 National Conference of State Legislatures, Genetics and Health Insurance
State Anti-Discrimination Laws (2005) available at http://www.ncsl.org/
programs/health/genetics/ndishlth.htm. (showing table of "Genetics and Health
Insurance State Anti-Discrimination Laws") (last visited Mar. 3, 2006) (on file
with the North Carolina Journal of Law & Technology).
66 National Human Genome Research Institute, Executive Order 13145 to
Prohibit Discrimination in Federal Employment Based on Genetic Information,
Feb. 8, 2000, available at http://www.genome.gov/10002084 (citing Executive
Order 13145 signed on Feb. 8, 2000) (last visited Mar. 3, 2006) (on file with the
North Carolina Journal of Law & Technology).67 National Human Genome Research Institute, President Clinton's Comments
on the Signing of Executive Order 13145, Feb. 8, 2000, available at
http://www.genome.gov/10002346 (last visited Mar. 3, 2006) (on file with the
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coverage, the possibility of genetic discrimination in the workplace
has also given rise to state legislation since the 1990s. 68 Today,
most states have enacted legislation that prohibits genetic
discrimination in the workplace and in obtaining health insurance
coverage.69 In addition, many bills are being introduced at the state
level seeking to clarify existing legislation or aiming to introduce
protection against genetic discrimination.7 ° These state efforts
have been the impetus to pass similar legislation at the federal
level.71
In February 2005, the Senate unanimously passed Senate Bill
S.306, "Genetic Information Non-Discrimination Act of 2005," by
a vote of 98-0.72 This bill mirrors prior Senate legislation
prohibiting genetic discrimination in the workplace and in health
insurance coverage.73  The bill is pending in the House.74  The
North Carolina Journal of Law & Technology). Bill Clinton made the following
statement:
We must not allow advances in genetics to become the basis of
discrimination against any individual or any group. We must never
allow these discoveries to change the basic belief upon which our
government, our society, and our system of ethics is founded-that all
of us are created equal, entitled to equal treatment under the law.
Id.
68 See Billings, infra note 69 (citing Sally Lehrman, California Law will
Prohibit Genetic Discrimination, 371 NATURE 468 (1994)).
69 Paul R. Billings, Genetic Nondiscrimination, 37 NATURE GENETICS 559,
559-60 (2005). See also National Human Genome Research Institute, Genetic
Discrimination in Health Insurance (2005), available at
http://www.genome.gov/ (follow "Educational Resources" hyperlink; then go to
"Factsheets" hyperlink and select "Genetic Discrimination in Health Insurance"
hyperlink) (last visited Mar. 3, 2006) (on file with the North Carolina Journal of
Law & Technology). "Meanwhile, 41 states have enacted legislation related to
genetic discrimination in health insurance and 31 states have adopted laws
regarding genetic discrimination in the workplace." Id.
70 See Billings, supra note 69, at 559.
71 See Billings, supra note 69, at 559.
72 Experts Say Bill Banning Genetic Discrimination Faces Tough Road, 8 HR
ON CAMPUS 4 (Apr. 1, 2005).
73 The Senate passed an identical bill in 2003. See S.1053, 108th Cong.
(2003).
74 National -Human Genome Research Institute, Genetic Discrimination,
available at http://www.genome.gov/ (follow "Policy & Ethics" hyperlink; then
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House bill, entitled "Genetic Information Non-Discrimination Act
of 2005," (HR 1227), was introduced in March 2005. 7" At present,
the bill awaits deliberations in the Committee on Education and the
Workforce, the Committee on Energy and Commerce, and the
Committee on Ways and Means.76
The pending legislation proposes the protection of workers in
all industries from discrimination based on genetic information."
The legislation would limit how employers and organizations, such
as unions and labor committees, could use genetic information in
hiring and other employment decisions.8  Furthermore,
"employers, labor organizations, employment agencies, and joint
labor-management committees are prohibited from using,
acquiring or disclosing the genetic information of an individual or
his/her family members."79 In stark contrast to the ruling in the
labor dispute involving the German teacher, protection of genetic
information would thereby extend to the employee's spouse and all
of the employee's blood-relatives as well as any adopted children.
follow "Genetic Discrimination" hyperlink) (last visited Mar. 3, 2006) (on file
with the North Carolina Journal of Law & Technology).
75 id.
76 id.
77 S. 306, 109th Cong. (2005) (introduced Feb. 7, 2005 by Sen. Olympia J.
Snowe).
78 Id. (describing the use of genetic information in the employment context:
"Title II-Employment: The bill would prohibit employers, labor organizations,
employment agencies and joint labor-management committees from using
genetic information to discriminate against an individual through hiring, firing,
or other employment decisions. Employers are also prohibited from requesting,
requiring, or purchasing genetic information of employees.").
9 Id.
80 See Genetic Information Nondiscrimination Act of 2003, S. REP. No. 108-
122, at 26 (2003). Family history should be included in the definition of genetic
information because:
For this reason, the committee believes it is important to include family
medical history in the definition of "genetic information." In so doing,
the committee followed the recommendations of numerous leading
experts in genetic science. Further, the bill applies to spouses and
adopted children of an individual because of the potential
discrimination an employee or member could face because of an
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Inadvertently obtaining genetic information, while not
sanctioned by the legislation, is not penalized, as long as there is
no discriminatory use.8" It is worth noting that the Senate bill
stipulates that genetic information from employees may be
collected to maintain employee health. For example, genetic
information can be used to limit permanent health effects from
workplace exposure to dangerous substances.82 However, this use
is explicitly limited by a prohibition on disclosing genetic
information of the employee to anyone but the employee, health
researchers, or others in compliance with federal and state law.83
If genetic information is disclosed or subsequently used to
discriminate, penalties may be levied using prior anti-
employer's or other entities' concern over potential medical or other
costs and their effect on insurance rates.
Id.
81 Id. at 27. Some of the problems encountered when dealing with the genetic
information at work include:
[t]he first exception addresses the so-called "water cooler problem," in
which an employer unwittingly receives otherwise protected genetic
information in the form of family medical history through casual
conversations with a worker. The committee recognizes that
conversations among co-workers about the health of a family member
are common and intends to prevent such normal interaction from
becoming the basis of litigation under this Act. Without the exception,
the committee is concerned that discussion in the workplace of a family
member's health condition that is genetically based could be interpreted
as an employer requesting or requiring genetic information from an
individual. Under the legislation, an employer, labor organization,
employment agency, or joint labor-management committee will not
violate the ban on acquiring genetic information where it "inadvertently
requests or requires family medical history" of the individual or family
member of the individual.
Id.
82 Id. ("The second exception-which preserves employer-sponsored
wellness programs-is necessary to achieve the bill's stated goal of encouraging
employees to take advantage of genetic technologies and opportunities to
improve human health without fear of discrimination by their employer.").
Id. ("[S]afeguards must be in place to ensure that the sponsoring employer,
labor organization, employment agency, or joint labor-management committee
does not have access to individually identifiable health information, as defined
under the HHS medical privacy regulations.").
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discrimination legislation such as Title VII of the Civil Rights
Act." This would align one's genetic information with
discriminatory parameters associated with race, color, sex, and
religion. Claims would be filed through the Equal Employment
Opportunity Commission ("EEOC") or the appropriate state
agency.85 Currently, disparate impact claims are not permitted, but
the bill directs the formation of a commission six years after
enactment to determine whether disparate impact claims should be
permissible.86
Legislation at the federal level would create a uniform set of
rules related to workplace discrimination, comparable to the
American with Disabilities Act ("ADA"), which prohibits
discrimination based on disability." In this context, it is significant
that the ADA protects workers from workplace discrimination in
some circumstances, such as in cases where the disease is evident
84 See S. REP. No. 108-122, at 44 (2003).
81 Id. at 29.
86 See S. REP. No. 108-1053, at 29 (2003). Future developments may alter the
current recommendations:
[d]ue to the unique nature of genetic information and our current
understanding of this developing area of science, the Committee has
determined that only disparate treatment cases should be permitted
under this legislation at this time. The bill contemplates that the
science could change in the future and has called for the creation of a
study commission six years after the date of enactment to review this
issue. The Commission's purpose is to advise Congress on the
advisability of providing for a disparate impact cause of action in the
future.
Id.
87 Id. at 30. The available statutes under which individuals may seek redress
include:
[t]he Committee recognizes that both the ADA and the Rehabilitation
Act of 1973 regulate the use of genetic information in some manner.
The first rule of construction expressly states that nothing in Title II
shall be construed to limit the rights or protections of an individual
under those two laws. Individuals remain free to seek redress for
violations of the ADA, the Rehabilitation Act, and the Genetic
Information Nondiscriminatin Act.
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and is associated with some degree of disability."8 Until uniform
federal guidelines cover all workers, the ADA may also protect the
job candidate from discrimination based on the possibility of
developing a disease. 9
Extending protection under the ADA to cases involving genetic
discrimination has been achieved in a few cases.9 ° The courts in
these important, but rare, cases have ruled in favor of more
protection from employment-related predictive tests and have
shown the need to establish basic rules that address recent
developments in genetic testing.9' These cases are analyzed in
more detail in Part IV.
IV. GENETIC TESTING IN THE WORKPLACE-IMPLICATIONS OF
PRIOR CASE LAW
A. Genetic Testing in the Workplace-Two Case Studies
While only a few cases have dealt with genetic discrimination
at work, research completed by Harvard and Stanford universities
includes the case of a worker at risk for Huntington's and
88 Bryce A. Lenox, Genetic Discrimination in Insurance and Employment:
Spoiled Fruits of the Human Genome Project, 23 DAYTON L. REv. 189, 205-06
(1997) ("Two current sources of federal protection against genetic
discrimination in employment and insurance are the Americans with Disabilities
Act (ADA) and the Health Insurance Portability and Accountability Act of
1996.").
89 See S. REP. No. 108-122, at 27 (2003) ("The second exception-which
preserves employer-sponsored wellness programs-is necessary to achieve the
bill's stated goal of encouraging employees to take advantage of genetic
technologies and opportunities to improve human health without fear of
discrimination by their employer.").
90 Norman-Bloodsaw et al. v. Lawrence Berkeley Lab., 135 F.3d 1260, 1273
(1998) (describing the limits of the ADA protection related to privacy: "Thus,
the ADA imposes no restriction on the scope of entrance examinations; it only
guarantees the confidentiality of the information gathered, § 12112(d)(3)(B), and
restricts the use to which an employer may put the information.") (emphasis in
original).
91 Billings, supra note 69, at 559-60.
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illustrates workplace discrimination due to genetic risk.9" In the
case, a twenty-four year old woman was fired from her job, despite
three promotions and outstanding performance reviews in the prior
eight months. 3 Once the young woman revealed to her employer
that a family member had Huntington's, she received a bad
performance review without any examples of poor performance
being cited. A co-worker informed her that the employer was
worried about the young woman being at risk for developing
Huntington's Chorea. 4  This case illustrates that genetic
discrimination is not only a reality in Germany, but also the United
States.
Up to now, very little case law involves genetics discrimination
in the workplace, possibly because genetic testing is a very recent
technological development. The following two cases involve
genetic testing, in addition to possible elements of racial
discrimination and efforts to cut health-care costs. In Norman-
Bloodsaw v. Lawrence Berkeley Laboratory, several employees
filed a lawsuit against their employer, Lawrence Berkeley
Laboratory, for including testing for "highly private and sensitive
medical and genetic information, such as syphilis, sickle cell trait,
and pregnancy, in a general employee health examination."95 The
plaintiffs brought charges against the employer based on violations
of Title VII of the Civil Rights Act of 1964, the ADA, and their
right to privacy as guaranteed by both the United States and the
State of California Constitutions.96 Since the ADA is considered to
offer protection against genetic testing at the workplace, this
Comment will limit the analysis to the claims that were brought
under the ADA.97 The court in Norman-Bloodsaw agreed with the
92 Marisa A. Pagnattaro, Genetic Discrimination and the Workplace:
Employee's Right to Privacy v. Employer's Need to Know, 39 AM. Bus. L. J.
139, 155 (2001).
93 Id. (citing Lisa N. Geller et al., Individual, Family, and Societal Dimension
of Genetic Discrimination: A Case Study Analysis, 2.1 SCI. & ENGINEERING
ETHICS, 71-88 (1996)).
94 Id.
9' 135 F.3d 1260, 1264 (9th Cir. 1998).
96 Id.
97 One problem faced by the plaintiffs in Norman-Bloodsaw is the fact that
some testing took place prior to the enactment of the ADA. Since the ADA does
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plaintiffs that the employment-entrance exams they were subjected
to were one of the categories of medical testing covered by the
ADA.98 The court went on to clarify that the ADA is not intended
to protect against the collection of information through medical
testing, only to safeguard the confidentiality of such information
and prevent the use of such information for discriminatory
purposes.99
The Ninth Circuit affirmed the district court's dismissal of the
ADA-based claims for two reasons. First, the plaintiffs did not test
positive for any medical condition, nor were they subjected to
discriminatory action by the employer. Second, the ADA does not
limit the scope of such exams to job-relatedness or business
purposes necessity.'0 0 According to the court, the only possible
claim under the ADA would be an allegation that the employer
failed to properly safeguard the collected information as mandated
not apply retroactively, only testing done after the ADA was passed could be
considered by the courts.
98 Norman-Bloodsaw, 135 F.3d at 1273. The court goes on to explain what
categories of medical inquiries are covered by the ADA:
The ADA creates three categories of medical inquiries and
examinations by employers: (1) those conducted prior to an offer of
employment ("preemployment" inquiries and examinations); (2) those
conducted "after an offer of employment has been made" but "prior to
the commencement of. . . employment duties" ("employment entrance
examinations"); and (3) those conducted at any point thereafter. It is
undisputed that the second category, employment entrance
examinations, as governed by § 12112(d)(3), are the examinations and
inquiries to which Fuentes and Garcia were subjected.
Id.
99 Id.
100 Id. ("Because the ADA does not limit the scope of such examinations to
matters that are 'job-related and consistent with business necessity,' dismissal of
the ADA claims was proper."). The Supreme Court came closest to addressing
the problem of asymptomatic individuals being discriminated against and their
possible recourse under the ADA in Bragdon v. Abbott, 524 U.S. 624 (1998). In
Bragdon, an individual with an HIV infection, but not full-blown and
symptomatic AIDS, sought protection under the ADA. The Court justified
extension of the ADA to an HIV-positive, but otherwise asymptomatic person
on the fact that the HIV infection constituted a "physical or mental impairment
that substantially limits one or more of the major life activities." Bragdon, 524
U.S. at 630 (referring to limited reproductive ability of the plaintiff).
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under §12112(d)(3)(B) of the ADA.' Since the plaintiff did not
specifically allege such a violation, the Ninth Circuit found no
possible basis for a violation of the ADA regulations by the
employer.0 2  The narrow reading of the ADA with respect to
genetic testing underscores the need for a comprehensive law that
protects employees against workplace genetic testing and is not
limited to guaranteeing proper use of any information collected
through such testing.
Another case involved a lawsuit filed by the Brotherhood of
Locomotive Engineers with the EEOC on behalf of workers at
Burlington Northern Santa Fe Railroad ("BNSF"). °3 Here, the
employer allegedly used genetic tests to identify a possible basis
for symptoms resembling carpal tunnel syndrome in order to avoid
financial responsibility for the medical treatment.1°4 The tests were
allegedly not done on a voluntary basis; every employee who
submitted a claim for work-related carpal-tunnel syndrome was
forced to submit to a blood draw to test for a chromosome 17
deletion. 5 This genetic testing was done despite the lack of a firm
101 Id. at 1274.
102 Id. The plaintiffs lost under the ADA because:
[t]o the extent that one can construe the complaint to allege that the
defendants are in violation of § 12112(d)(3)(B), the bare allegation that
defendants have not provided, or adequately described, safeguards fails
to state a violation of the ADA requirements as set forth in
§ 12112(d)(3)(B) or as implemented in Department orders.
Id.
103 See S. REP. No. 108-122 at 9 (2003) (citing testimony of David Escher,
HELP Committee Hearing, July 25, 2001).
104 See Burlington Northern Santa Fe Railroad Employees Subjected to
Genetic Testing for Carpal Tunnel Syndrome, available at http://www.sboh.
wa.gov/Priorities/Genetics/GTF2002_02-25/documents/TabO5-
BNSF_summary.pdf) (last visited Mar. 3, 2006) (on file with the North Carolina
Journal of Law & Technology).
105 U.S. Equal Employment Opportunity Commission, EEOC Petitions Court
to Ban Genetic Testing of Railroad Workers in First EEOC Case Challenging
Genetic Testing under Americans with Disabilities Act, Feb. 9, 2001, available
at http://www.eeoc.gov (follow hyperlink "news archive"; then scroll down to
February 2001 and select "EEOC Petitions Court To Ban Genetic Testing Of
Railroad Workers In First EEOC Case Challenging Genetic Testing Under
Americans with Disabilities Act") (last visited Mar. 3, 2006) (on file with the
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scientific basis that a direct link existed between the chromosomal
alteration and the development of carpal tunnel syndrome."6
Based on the frequency of carpal tunnel syndrome in the workers,
the test for mutation could not have explained all, if any, of the
work-related injuries."°7 In addition, one worker stated that he was
threatened with losing his job if he refused to submit to the
testing."' Interestingly, in support of the plaintiffs' lawsuit, the
EEOC Commissioner stated that the genetic testing violated the
ADA."0 9 The commissioner argued that under the ADA, only
work-related testing that was based on business necessity was
North Carolina Journal of Law & Technology). A deletion on a chromosome
indicates that a small part of the chromosome is missing. This change in the
chromosome can be associated with the development of diseases, if the missing
chromosomal region contained important genes. In this case, the chromosome
17 deletion affected the PMP 22 gene. See NC Center for Genomics, infra note
107.106 id.
107 North Carolina Center for Genomics and Public Health, The Burlington
Northern Case Workplace Genetic Testing, available at
http://www.sph.unc.edu/nccgph/phgenetics/burlington.htm (last visited Mar. 3,
2006) (on file with the North Carolina Journal of Law & Technology) The
testing in Burlington was not appropriate because:
HNPP is estimated to occur in approximately 2-5 people per 100,000.
It is a rare condition. Perhaps 10% of Burlington Northern workers
were afflicted with carpal tunnel syndrome. The PMP 22 gene could
not begin to explain all those cases-it is far too rare a syndrome. It
appears that the company vastly overestimated the predictive value of
the genetic tests.
Id.
108 See id.
109 U.S. Equal Employment Opportunity Commission, supra note 105. EEOC
Commissioner Paul Steven Miller explained:
The Commission takes the position that basing employment decisions
on genetic testing violates the ADA. In particular, employers may only
require employees to submit to any medical examination if those
examinations are job related and consistent with business necessity.
Any test which purports to predict future disabilities, whether or not it
is accurate, is unlikely to be relevant to the employee's present ability
to perform his or her job.
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permitted,"' thereby expanding the protection under the ADA as
compared to the holding in Norman-Bloodsaw. The EEOC used
the definitions of "individual with a disability" and "prohibited
inquiries and examinations" of the ADA to explain their opposition
to the testing done by BNSF."' This case was settled out of
court"2 for $2.2 million."3
B. Workplace-Related Testing-Employer's Duty to Disclose
The aforementioned cases demonstrate the need for legislation
that creates a unified national framework for the use of genetic
information in the workplace. Genetic testing should be regulated
to protect workers against invasions of privacy from unwarranted
and overreaching tests. At the same time, genetic testing should
also be regulated on the federal level to protect employers. Failure
to disclose potential health risks that were revealed in pre-
employment physicals may expose the employer to subsequent
liability if the employment candidate should develop an incurable
disease or suffer other negative consequences due to
nondisclosure.
In Coffee v. McDonnell-Douglas Corporation,"4 the Supreme
Court of California held that "an employer generally owes no duty
to his prospective employees to ascertain whether they are
physically fit for the job they seek, but where he assumes such
duty, he is liable if he performs it negligently." In this case, a pre-
employment physical revealed a blood disorder indicative of a
possible cancerous disease that the employer did not disclose to the
110 See id.
"'1 See Burlington Northern Santa Fe Railroad Employees Subjected to
Genetic Testing for Carpal Tunnel Syndrome, available at
http://www.sboh.wa.gov/Priorities/Genetics/GTF2002_02-25/documents/TabO5-
BNSF_summary.pdf (last visited Mar. 3, 2006) (on file with the North Carolina
Journal of Law & Technology) ("The EEOC considers that employers who
discriminate against employees on the basis of predictive genetic tests "regard"
the employees as having a disabling impairment and are therefore acting in
violation of the ADA.").
112 North Carolina Center for Genomics and Public Health, supra note 107.
The case was settled in May 2002.
1131d.
114 503 P.2d 1366, 1370 (Cal. 1972).
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prospective employee, and after working for the company for
several months the employee collapsed due to bone marrow
cancer."'  The court held that the company violated a duty to
properly handle the interpretation of blood tests.1 6 Even though
the blood test did not involve genetic testing, it is easy to see how
pre-employment genetic testing can put a similar burden on the
employer to handle test results as the court required in Coffee. In
this context, it is important to note that genetic testing for known
workplace exposures to hazardous substances is specifically
allowed by the German NEC's recommendations" 7 and by Senate
bill S.306."' Also, under the Occupational Safety and Health Act
("OSHA"), employees have a right to access their employment
medical records if they are, or have been, exposed to toxic or
harmful substances at work."19
However, a current employee's right to access employee
records, which have to be kept by the employer for the duration of
the employment plus thirty years,' does not extend to job
applicants.' As such, as far as the job applicants are concerned,
115 Lori B. Andrews & Ami S. Jaeger, The Human Genome Initiative and the
Impact of Genetic Testing and Screening Technologies: Confidentiality of
Genetic Information in the Workplace, 17 AM. J. L. & MED. 75, 90 (1991).
"' See NEC, Predictive Health Information in Pre-Employment Medical
Examinations, Aug. 16, 2005, at 59, http://www.ethikrat.org (follow "English
version" hyperlink; then follow "Publications" hyperlink and select "Predictive
health information in pre-employment medical examinations" hyperlink)
(Recommendation #9) (last visited Mar. 3, 2006) (on file with the North
Carolina Journal of Law & Technology).
118 See S. REP. No. 108-122 at 27 (2003) ("The second exception-which
preserves employer-sponsored wellness programs-is necessary to achieve the
bill's stated goal of encouraging employees to take advantage of genetic
technologies and opportunities to improve human health without fear of
discrimination by their employer.").
119 Access to Employee Exposure and Medical Records, 29 C.F.R.
§ 1910.1020 (1990) (cited by Andrews & Jaeger, supra note 115).
120 Id. at § 1910.1020(d)(1)(i)(A), (B). It is also important to note that if an
employee works for the less than one year at the company, the employer has the
option of releasing the records kept to the employee and thereby free himself of
any duty to maintain the records for the statutory period.
§ 1910.1020(d)(1)(i)(C).
121 Id. at § 1910.1020(c)(4).
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their best and possibly only protection is the ADA and its
prohibition to discriminate based on medical testing. However,
based on Norman-Bloodsaw, the ADA does not prohibit genetic
testing for employment purposes per se, merely discrimination
based on the results of such testing.
The proposed legislation under the House and Senate version
of the "Genetic Information Non-Discrimination Act of 2005"
would go significantly further. Instead of simply limiting the right
of the employer to perform medical tests without appropriate
employee consent, the proposed legislation would extend to
prospective employees and prevent genetic discrimination in hiring
decisions. 2 In addition to privacy concerns, the use of genetic
testing also raises concerns, particularly among minorities, about
the potential abuse of genetic testing for discriminatory purposes.
C. Genetic Testing in the Workplace-Modern Backdoor to Old-
Fashioned Discrimination?
In Norman-Bloodsaw, one aspect of the case the court
overlooked in its analysis was the possible use of genetic testing
for race-based discrimination. While the pregnancy testing done
by Lawrence Berkeley Laboratory was limited to female
workers,'23 the testing for sickle cell anemia was limited to
Affican-Americans.2 4 Interestingly, the Norman-Bloodsaw court
acknowledged that testing for this disease was stopped by the
122 See S.1053, 108th Cong. (2003). See § 202(b)(5). Testing by the
employer is allowed in the following situations:
the information involved is to be used for genetic monitoring of the
biological effects of toxic substances in the workplace, but only if--(A)
the employer provides written notice of the genetic monitoring to the
employee; (B)(i) the employee provides prior, knowing, voluntary, and
written authorization; or (ii) the genetic monitoring is required by
Federal or State law.
Id.
123 Norman-Bloodsaw v. Lawerence Berkley Lab., 135 F.3d 1260, 1265 (9th
Cir. 1998). "They also allege that only black employees were tested for sickle
cell trait and assert the obvious fact that only female employees were tested for
pregnancy." Id.
124 id.
[VOL. 7:487
PREDICTIVE TESTING
employer in part because African-American newborns were
routinely tested for the disease by then.15 The two plaintiffs that
had possible claims under ADA had negative test results, 126 and
one can only speculate whether positive results for sickle-cell
anemia would have resulted in discriminatory hiring decisions.
However, there is evidence that the availability of genetic testing
may be abused to discriminate against certain population groups.
27
Sickle-cell anemia is an incurable and debilitating disease,
prevalent in African-Americans. 128 In an age of ever-increasing
health care costs and fiscal concerns governing medicine,
129
employers that provide comprehensive health care coverage to
their employees may be tempted to reduce costs for everyone by
only hiring people without potential or obvious genetic diseases.
125 Norman-Bloodsaw, 135 F.3d at 1274. The following rationale was
provided by the court to explain why the claims by the plaintiffs failed:
Defendants have not carried their heavy burden of establishing either
that their alleged behavior cannot be reasonably expected to recur, or
that interim events have eradicated the effects of the alleged violation.
First, they do not contend that the Department will never again require
or permit, or that Lawrence will never again conduct, the tests at issue.
They assert only that syphilis testing was discontinued because of its
limited usefulness in screening healthy populations, and that sickle cell
trait testing was discontinued as redundant of testing that most African-
Americans now receive at birth.
Id.
126 Id. at 1273. ("Plaintiffs do not allege that defendants made use of
information gathered in the examinations to discriminate against them on the
basis of disability; indeed, neither Garcia nor Fuentes received any positive test
results.").
127 Lori B. Andrews, Past as Prologue: Sobering Thoughts on Genetic
Enthusiasm, 27 SETON HALL L. REV. 893 (1997) (providing a general discussion
on the possible discriminatory uses associated with genetic testing).
128 Charles Pegelow & Ashok Raj, Sickle Cell Anemia, Jun. 23, 2004,
available at http://www.emedicine.com/ped/topic2096.htm (last visited Mar. 3,
2006) (on file with the North Carolina Journal of Law & Technology). It is
ironic that the plaintiffs in Norman-Bloodsaw allege discrimination based on the
testing for sickle cell anemia, when the National Sickle Cell Anemia Control
Act was passed by congress in 1972 to ensure adequate federal funding for
voluntary testing as a result of efforts by black leaders that alleged insufficient
medical attention to this disease. See Pagnattaro, supra note 92 at 146-47.
129 Andrews, supra note 127, at 896.
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In the United States, genetic science has been abused for
discriminatory purposes, perhaps most prominently during the
eugenics movement. 3 ' Initially, forced sterilization was thought to
be a cost-effective remedy for improving the genetic make-up of
society. 3' The most infamous case involving restricting personal
rights in the name of eugenics may be the 1927 case of Buck v.
Bell,12 where the plaintiff, Carrie Buck, underwent forced
sterilization based on the judgment of Justice Holmes that "three
generations of imbeciles" are enough.' It was later shown by
Paul Lombardo that Carrie Buck was not an imbecile, but had done
well in school, as had her daughter, and that the likely reason for
the sterilization was her "immoral" behavior for having a child out
of wedlock.'34 Shockingly, Carrie Buck was not only forcibly
sterilized, but she was also confined to an institution for the
"feebleminded."' 35 Based on the history of abusing genetic science
for discriminatory purposes, modem society must take extra
precautions not to repeat past mistakes.
Evidence indicates that access and use of genetic testing may
be biased in favor of Caucasians.136  Lori Andrews.37 has
130 Webster's New Collegiate Dictionary defines eugenics as "a science that
deals with the improvement (as by control of human mating) of hereditary
qualities of a race or breed." See WEBSTER'S NEW COLLEGIATE DICTIONARY
428 (9th ed. 1990).
131 Andrews, supra note 127, at 895.
132 274 U.S. 200 (1927).
133 Id. at 207.
134 Paul A. Lombardo, Three Generations, No Imbeciles: New Light on Buck
v. Bell, 60 N.Y.U. L. REv. 30, 53 (1985).
135 Andrews, supra note 127, at 906-07 (discussing the political use of
genetics exemplified by Buck v. Bell).
136 Conference Abstract Section 15: Posters and Multi-Media Presentations,
29 J.L. MED. & ETHICS 42 (2001) (citing an abstract by Miriam Kuppermann,
Elena Gates, & A. Eugene Washington, Racial/Ethnic Differences in Prenatal
Diagnostic Test Use and Outcomes: Preference, Socioeconomics, or Patient
Knowledge?). The results of the cited study indicate that:
Latinas and African-Americans were much less likely to undergo
prenatal diagnosis than were whites and Asians. Racial/ethnic
differences exist in prenatal diagnostic test use and associated outcomes
in women ages 35 and older. Socioeconomic factors are partially
responsible. Further research is needed to determine the roles of
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summarized several studies that indicate disparate treatment of
women and ethnic groups through availability of genetic testing or
use of informed consent prior to genetic testing. 38  Studies
comparing the use of informed consent for genetic testing related
to cystic fibrosis, a genetic disorder most prevalent in Caucasians,
and sickle cell anemia, which is prevalent in African-Americans,
indicate that informed consent procedures are more prevalent in
the identification of potential carriers of the cystic fibrosis gene,
while screening for sickle cell anemia is done with minimal
informed consent procedures.'39
Notably, this analysis may compare two diseases that are very
different in terms of the effect that early diagnosis has on the
carriers. Cystic fibrosis is caused by mutations in one gene, but the
number of mutations identified in the gene is extensive, and
research illustrates that some carriers of the disease will not show
any phenotypic effects of the disease until late in life and that the
phenotypic effects in patients diagnosed with cystic fibrosis vary
greatly. 4 ° In addition, early intervention in cystic fibrosis patients
will never cure the disease and there is little therapy available in
terms of preventing complications. 4 ' By contrast, sickle cell
anemia is a disease with a clear phenotypic effect that is easily
identified in testing. Testing for sickle cell anemia may be likened
to testing in neonates for phenylketonuria ("PKU"), a disorder in
structural issues in the delivery of care, provider attitudes, patient
education, patient preferences, and other factors.
Id.
137 Lori B. Andrews is a Distinguished Professor of Law and the Director of
the Institute for Science, Law & Technology at the Chicago-Kent College of
Law. She has published more than 100 articles on genetics, alternative modes of
reproduction, and biotechnology. Her biography can be found at
http://www.kentlaw.edu (follow hyperlink "Faculty" and select "full time
faculty" under Faculty lists hyperlink; then select "Lori B. Andrews) (last visited
Mar. 3, 2006) (on file with the North Carolina Journal of Law & Technology).
138 Andrews, supra note 127.
13 Id. at 909-10.
140 Jeffrey S. Wagener & Aree A. Headley, Review: Cystic Fibrosis: Current
Trends in Respiratory Care, 48 RESPIR. CARE 234, 235 (2003).
141 Samuel L. Moskovitz, Ronald L. Gibson, & Eric L. Effman, Review:
Cystic Fibrosis Ling Disease: Genetic Influences, Microbial Interactions, and
Radiological Assessment, 35 PEDIATR. RADIOL. 739, 746-48 (2005).
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which, similar to sickle cell anemia, early diagnosis can limit the
effects of the underlying genetic alteration and in which a
conclusive test can easily be done in the newborn. 142 In both sickle
cell anemia as well as phenylketonuria, DNA testing is not
required for a conclusive diagnosis, even though the blood testing
involved will point towards the carriers having the relevant
mutations. 4 1
Nevertheless, Lori Andrews rightly points to the long history of
discriminatory uses of genetic testing,'" and cases such as
142 March of Dimes, Newborn Screening Recommendations, available at
http://www.marchofdimes.com/ (select hyperlink "Professionals and
Researchers"; then select "Newborn screening" hyperlink and open the
document "March of Dimes Newborn Screening Recommendations") (last
visited Mar. 3, 2006) (on file with the North Carolina Journal of Law &
Technology). While access to medical care may limit the benefits of early
detection, antibiotic treatment in neonates suffering from sickle anemia
"dramatically reduces the risk of these infections and the deaths that result from
them." Id.
143 The following information is compiled from the Mayo Clinic Information
about Screening and Diagnosis of PKU, cystic fibrosis, and sickle cell anemia.
In Phenylketonuria, the underlying genetic mutation is affecting the gene for
metabolizing an amino acid called phenylalanine. Missing this enzyme will
result in high levels of phenylalanine in the blood that can be detected by a
simple blood test without involving DNA extraction. See www.mayoclinic.com/
(follow hyperlink "Diseases and Conditions"; follow hyperlink under "P" and
select "phenulketonuria"; section "Screening and Diagnosis"). Similarly, sickle
cell anemia can be detected using a simple blood test that does not require DNA
extraction. See www.mayoclinic.com. (follow hyperlink "Diseases and
Conditions"; follow hyperlink under "S" and select "sickle cell anemia"; section
"Screening and Diagnosis"). Newborns are screened for both diseases, since
early intervention is essential to prevent some of the complications associated
with the diseases. By contrast, the standard test for cystic fibrosis is not blood-
based. A sweat test is performed to determine the salt levels, since cystic
fibrosis patients have consistently high salt levels in the sweat. In newborns,
this test is not reliable during the first month of life and therefore physicians
either delay the test until the baby is several months old or perform a genetic
test. See www.mayoclinic.conL/ (follow hyperlink "Diseases and Conditions";
follow hyperlink under "C" and select "cystic fibrosis"; section "Screening and
Diagnosis"). Delaying the diagnosis of cystic fibrosis beyond the newborn will
not result in any permanent disability to the baby. (last visited Mar. 3, 2006) (on
file with the North Carolina Journal of Law & Technology).
144 Andrews, supra note 127, at 909-10.
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Norman-Bloodsaw indicate that lack of informed consent and
targeting of specific population groups for predictive testing
exemplifies problems in the way society is handling access to
modem genetic tools. It is equally important to point out that not
all advocates of minority rights are in favor of greater access to
genetic testing; some warn that efforts to equalize access to genetic
testing may also be discriminatory. The split opinion regarding the
approach that best includes minorities in the genetics revolution is
addressed in Part V.
V. INDIVIDUALIZED MEDICINE AND MINORITIES
"Once a tool is developed there are considerable
pressures for implementation."'45
The sequencing of the human genome and the availability of
high throughput genotyping technologies'46 create powerful tools
in the hands of researchers. A more individualized medicine
approach can optimize drug efficacy, limit possible side-effects of
prescription drugs, and improve the effectiveness of medical
treatments in general.'47 However, individualized medicine also
puts additional pressures on physicians, health care providers and
other groups with access to personal information, including genetic
information, to safeguard the privacy of patients. The public
outcry following the approval by the Federal Drug Administration
of a blood pressure medication geared towards African-Americans
may be indicative of the future challenges facing individualized
medicine.'48 Since African-Americans were suffering from heart
145 See Wiesenthal, supra note 2.
146 "High throughput technologies" are defined as genotyping methods that
involve robotics and allow screening of large numbers of samples in one
experiment. See Michael M. Shi, Enabling Large-Scale Pharmacogenetic
Studies by High-Throughput Mutation Detection and Genotyping Technologies,
47 CLINICAL CHEM. 164 (2001).
147 Jim Hopkins, Personalized Drugs Draw Biotech Dollars, USA TODAY,
Oct. 20, 2005, at lB.
148 CBS News, Drug Studied as Heat-Failure Treatment in African-
Americans, (Mar. 1, 2001), available at http://www.cbsnews.com/stories/
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disease at higher rates'49 than other ethnic groups, improved
treatments were demanded by some community activists. 5 ° Others
in the African-American community were concerned with the
precedent that drugs optimized for specific groups within the
population can set. 5' Akin to the reactions voiced by the Supreme
Court when dealing with cases involving affirmative action, some
view the preferential treatment of minorities as necessary to
overcome a history of discrimination,'52 while others view race-
specific prescription drugs as a first step on the way to
2002/01/31/health/main326980.shtml (last visited Mar. 3, 2006) (on file with the
North Carolina Journal of Law & Technology). The article describes the first
drug designed specifically for one ethnic group:
Estimates suggest that African Americans are twice as likely to die
from heart failure as whites. Now a drug manufacturer has announced
plans to study a drug called Bidil (a combination of the drugs
hydralazine HCI and isosorbide) which, if approved by the Food and
Drug Administration (FDA), it would be the first drug specifically
intended to treat heart failure in African-American patients.
BiDil, which is manufactured by NitroMed was subsequently approved on June
17, 2005. See Kennedy, infra note 149.
149 Val B. Kennedy, FDA Panel OKs Heart Drug for African-Americans, Jun.
17, 2005, available at www.marketwatch.com ("According to NitroMed, about
750,000 African-Americans have heart disease. In addition to suffering in
greater numbers, most do not respond as well to standard cardiac drugs as
patients of other ethnic backgrounds.").
150 Id. ("Because of this, BiDil has enjoyed considerable support from
African-American health activists, including the Association of Black
Cardiologists, which co-sponsored some the clinical trials.").
151 M. Gregg Bloche, Race-Based Therapeutics, NEW ENG. J. MED. 2035,
2036, Nov. 11, 2004. ("This argument is a reassuring response to concern that
emphasis on biologic differences among social groups risks stigmatizing some
groups and, in recent history, has led to much worse consequences.") (citing RJ
Lifton, The Nazi Doctors: Medical Killing and the Psychology of Genocide
(Basic Books, 1986)).
152 Grutter v. Bollinger, 288 F.3d 732, 737 (6th Cir. 2002) (cert. granted, 537
U.S. 1043 (2002) ("[I]ts admissions policy describes 'a commitment to racial
and ethnic diversity with special reference to the inclusion of students from
groups which have been historically discriminated against, like African-
Americans, Hispanics and Native Americans, who without this commitment
might not be represented in our student body in meaningful numbers.").
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discrimination against minorities. 53 The lessons from affirmative
action cases indicate that using genetics to create individualized
medical treatments harbors certain dangers, such as the fear of
race-based discrimination. Researchers and the Congress need to
be aware of these concerns and should strive to create as broad a
consensus as possible when proceeding with individualized
medicine.
Other methods of targeting minorities in medicine have been
received with less criticism. The National Institutes of Health have
focused on an increased inclusion of minorities in clinical trials in
an attempt to optimize the application of results to the population
as a whole."s4 One inherent concern of merely including minorities
at the levels at which they are present in the general population is
the fact that, in small studies, statistical power may not be high
enough to generate conclusive results. Increasing minority
enrollment above the population average in clinical trials dealing
with diseases from which minorities suffer to a disproportionately
high degree may again elicit concerns as raised by M. Gregg
153 Grutter v. Bollinger, 539 U.S. 306, 349 (2002) (Justice Thomas citing
Frederick Douglass: "In regard to the colored people, there is always more that
is benevolent, I perceive, than just, manifested towards us. What I ask for the
negro is not benevolence, not pity, not sympathy, but simplyjustice." ).
National Heart, Lung, and Blood Institute, National Institutes of Health,
Questions and Answers on Inclusion of Minorties and Women in Study
Populations, (Apr. 2002), available at http://www.nhlbi.nih.gov/ (follow
hyperlink "Funding Opportunities"; select hyperlink "Ethics, Populations, Data
Safety and Integrity, and Finance Issues"; select "Inclusion of Minorities and
Women in Study Populations--Questions and Answers" hyperlink) (last visited
Mar. 3, 2006) (on file with the North Carolina Journal of Law & Technology).
The NIH guidelines for inclusion of minorities and women state:
Ideally, women and minorities in the study population are in the same
proportions as in the U.S. population having the disease entity being
studied. If prevalence is unknown, the NHLBI standard for evaluation
of the proposed study population is the composition of the population
of the United States which, according to the 2000 census, is 51%
women and 25% minorities.
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Bloche, 5  even though such an increased enrollment of minorities
may be necessary to generate statistically interpretable results.
To complicate matters, geneticists have started to question the
importance of race as a parameter in genetic studies.156 The
increased use of high throughput genotyping has afforded scientists
the luxury of screening for larger numbers of single nucleotide
polymorphisms'5 7 and allowed a comparison between the so-called
"self-identified race" and the genetic background of a person.
Having more than 20% of participants in some studies self-identify
their racial background as different from their race based on
genetic screening'58 and the increase in interracial families'59 may
lessen the impact of race in genetics in favor of a truly
individualized approach to medicine. Some geneticists, therefore,
suggest an increased focus on the socio-economic environment
when analyzing genetic data and limiting self-identified race to an
initial screening tool. 6°
The preceding examples illustrate the difficulties encountered
by the increased use of genetics and some of the concerns that may
be raised with respect to the treatment of minorities. The
precedent set by the ADA for federal anti-discrimination laws and
the general acceptance of ADA standards for the treatment of
people with disabilities may serve as a guideline to expand the
ADA to the use of and access to genetic information. The eventual
goal should be parallel legislation based on a broad consensus that
155 See Bloche, supra note 151. Mr. Bloche is concerned that singling out
certain ethnic groups, even for what may initially seem like beneficial reasons,
could, in the long run, lead to possible stigmatization of these groups.
156 Alexandra E. Shields, et al., The Use of Race Variables in Genetic Studies
of Complex Traits and the Goal of Reducing Health Disparities: A
Transdisciplinary Perspective, AM. PSYCHOL. 60(1):77-103 (Jan. 2005).
157 Single nucleotide polymorphisms denote mutations that affect a single
nucleotide in the DNA sequence. A polymorphism is a specific point in the
human genome that shows variability, such as is seen in mutations. See Tefferi,
supra note 26.
158 Shields, supra note 156, at 90.
159 Ross Atkin, Facing Race, CHRISTIAN SCIENCE MONITOR, Jul. 25, 2001, at
11.
160 See Shields, supra note 156, at 95.
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specifically aims at mandating how genetic information should be
collected and accessed.
VI. CONCLUSION
Passing the pending legislation in the House, combined with
assurances by President Bush that he will sign such legislation,
should alleviate some of the concerns about genetic testing giving
rise to discrimination in the workplace.16' However, technological
advances have made genetic testing more affordable to employers
and increased the number of testable genetic diseases. 16 2 These
technological advances, as well as the affordability of genotyping,
have led to an increase in genetic testing in the workplace. For
example, as early as 1982, 1.6% of companies confirmed the use of
genetic testing for employment purposes.163 Later figures found six
to ten percent of employers conducting such testing in 1997."6
161 Office of Management and Budget, Statement of Administrative Policy,
(Oct. 14, 2003), available at http://www.whitehouse.gov/omb (follow hyperlink
"Statements of Admin. Policy" under Legislative Materials; then follow
hyperlink 108th Congress "First Session (2003)" and select S 1053 "Genetic
Non-Discrimination Act of 2003") ("The Administration is committed to
enactment of legislation to prohibit genetic discrimination in health insurance
and employment.") (last visited Mar. 5, 2006) (on file with the North Carolina
Journal of Law & Technology).
162 See Human Genome Project Information, Gene Testing, Feb. 27, 2006
available at http://www.doegenomes.org (follow hyperlink "Gene Testing"
under Medicine) (citing an extensive list of commonly tested genetic diseases,
such as cystic fibrosis, breast cancer linked to mutations in the BRCA1 and
BCRA 2 genes, Duchenne muscular dystrophy/Becker muscular dystrophy, etc.)
(last visited Mar. 3, 2006) (on file with the North Carolina Journal of Law &
Technology).
163 U.S. Congress, Office of Technology Assessment, Medical Monitoring and
Screening in the Workplace: Results of a Survey-Background Paper, OTA-BP-
BA-67, at 190 (U.S. Government Printing Office, October 1991).
164 Editorial Desk, Government Plan Threatens Patients' Privacy; Genetic
Discrimination, N.Y. TIMES, Sept. 17, 1997, at A30. When considering the
results, it is important to keep in mind that the reported frequency of genetic
tests may include tests that are merely blood-based, but do not include the
determination of genetic information. Id. See also University Publications of
America Employment Testing, AM4 Finds Uncertainty over Genetic Testing,
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Since twenty-two percent of employees at risk for genetic
conditions reported some form of discrimination, a federal law
may be the best way to create uniform regulations regarding the
use of genetic testing in the workplace.165
The NEC recommendations attempt to create such uniform
guidelines for Germany.166 While these guidelines are a step in the
right direction, some of the suggestions in the guidelines have been
met with criticism. For instance, the NEC guidelines set different
standards for employees in the public and private sectors, with
public servants being subject to more stringent testing due to the
increased responsibility of the state to cover disability payments in
case of a disease manifesting itself.'67 This is in contrast to the
current situation in the U.S., where the executive order by
President Clinton secures higher protection for federal employees
EMP. TESTING LAW & POLICY REPORTER, Dec. 1998, at 190. The study found
that some misconceptions exist as to what is genetic testing:
The AMA determined that "a great deal of misinformation and
uncertainty" existed about what constitutes genetic testing, according to
Eric Rolfe Greenberg, director of management studies. Upon closer
questioning, only nine human resource officers reported "true" genetic
testing programs; the remaining thirty-five withdrew their original
responses. Many considered that any medical test requiring a blood
sample was a genetic test, not just those tests for specific genetic
abnormalities that are associated with disease.
Readers should keep this lack of understanding in mind when assessing
information about genetic testing that originates from nonspecialists.* For a
discussion of the relevant 1997 findings, see Employment Testing 6 (July 1997):
116-17. *Please note that the 1997 results may also reflect a misunderstanding
of "genetic testing."
165 See Pagnattaro, supra note 92 (citing Lisa N. Geller et al., Individual,
Family, and Societal Dimension of Genetic Discrimination: A Case Study
AnaYsis, 2.1 SCI. & ENGINEERING ETHICS, 71-88 (1996)).
16 See NEC, supra note 55.
167 See NEC, supra note 55. The NEC specifically points this out in the
abbreviated English version of its recommendations. "The principles outlined
above cannot be applied without reservation to the appointment of civil servants.
In this instance, the employer assumes a duty of care towards, and an obligation
to provide for the welfare of, a civil servant that persist throughout the
employee's life." Id.
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than is currently in place for private sector workers.'68 Even more
troubling than the different standards is the NEC's rationale for
implementing these standards. 69 Citing increased health care costs
due to tenured status of public servants, the NEC uses a cost-
benefit analysis to justify deciding how much of a privacy invasion
is necessary to determine an employee's fitness for a job.7 ' This
disparate treatment, between public and private employers, would
contradict the notion of equality before the law, one of the reasons
cited by President Clinton for his executive order.'' The current
168 Executive Order No. 13145 (order to Prohibit Discrimination in Federal
Employment Based on Genetic Information, Feb. 8, 2000). The central tenet
that:
[T]he policy of the Government of the United States [is] to provide
equal employment opportunity in Federal employment for all qualified
persons and to prohibit discrimination against employees based on
protected genetic information, or information about a request for or the
receipt of genetic services. This policy of equal opportunity applies to
every aspect of Federal employment.
See 65 Fed. Reg. 6,877 (2000).
169 See NEC, supra note 55. Citing the duty of care assumed by the federal
government for civil servants, the NEC then goes on to state that genetic testing
may be demanded in certain cases including:
As provided in the regulations obtaining in the individual German
States on the appointment of severely disabled persons as civil servants,
it should be permissible for predictive and prognostic information to be
demanded and used only in the case of conditions and predispositions
with more than a 50% probability of having a non-negligible effect on
an applicant's health-related fitness within the next five years.
Id.
170 See NEC, supra note 55.
171 See President Clinton's Comments on the Signing of Executive Order
13145 (Feb. 8, 2000), available at http://www.genome.gov/10002346 (last
visited Mar. 3, 2006) (on file with the North Carolina Journal of Law &
Technology). President Clinton made the following statement to summarize the
main points of the executive order:
The executive order I will sign in just a couple of minutes will be the
first executive order of the 21st century to help meet this great 21st
century challenge. It prohibits the federal government and its agencies
from using genetic testing in any employment decision. It prevents
federal employers from requesting or requiring that employees undergo
genetic tests of any kind. It strictly forbids employers from using
genetic information to classify employees in such a way that deprives
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legislation in the United States suggests that privacy concerns
rather than cost-benefit analysis will be used as a basis for future
legislation. 172
It remains to be seen whether rising healthcare costs,173
combined with achieving some form of national health care,"' will
reduce or eliminate the bans on genetic testing currently in place or
proposed under the pending legislation. One thing is certain: with
the increased availability of high throughput genotyping
techniques and associated increased use of genetic testing, society
cannot afford to delay embarking on a comprehensive effort to
regulate genetic testing, unless it wants to risk establishing possible
discriminatory practices associated with genetic testing. The
public, the courts, and Congress must understand that despite
advances in genetic testing, affected persons will not be able to
have all their questions answered by a genetic counselor. It should
therefore be the duty of society as a whole to create a framework,
in which the genetic research can have the utmost benefit, while
minimizing the possible detrimental effects of genetic testing on
the individual. Passing and signing into law the "Genetic
them of advancement opportunities, such as promotion for overseas
posts. By signing this executive order, my goal is to set an example
and pose a challenge for every employer in America, because I believe
no employer should ever review your genetic records along with your
resume.
Id.
172 See NEC, supra note 55.
173 Nick Bunkley, Increased Costs May Stall Auto Industry; But Southeast
Michigan's Economy is Expected to Grow, Business Leaders Say, DETROIT
NEWS, Dec. 7, 2004, at 1C. The problems faced by employers' attempt to pay
for health insurance coverage include:
To compensate for increasing expenses, automakers are likely to offer
buyers fewer incentives next year, said J.T. Battenberg, Delphi Corp.'s
chairman and chief executive. The cost of materials has jumped 50
percent in the past year alone, and health insurance premiums are
expected to increase nearly 14 percent. Ford Motor Co., General
Motors Corp. and DaimlerChrysler AG paid a combined $9 billion for
employee health care in 2003.
Id.
174 Mike Dennison, Elections Heating Up as Tuesday Vote Nears, GREAT
FALLS TRIBUNE, June 6, 2004, at Al 11.
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Information Non-Discrimination Act" would be an important first
step. But as the ethics recommendations by the NEC indicate, the
devil is often in the details and amendments will have to be made
as physicians, employers, employees, and Congress learn how to
incorporate genetic testing into the workplace.
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